Identification and diagnosis of the infecting agent responsible for he
patitis C have only recently occurred. Recognition of an infecting age
nt distinct from that resulting in hepatitis A or B was made approxima
tely 50 years ago, However, the ability to screen and detect this agen
t was possible only after molecular biology studies which led to the c
loning of parts of the hepatitis C virus (HCV) and the development of
a diagnostic antibody test reported by Michael Houghton and colleagues
in 1989. The discovery and cloning of HCV has led to a greater unders
tanding of its relationship to acute and chronic hepatitis, cirrhosis,
primary liver cancer, and extrahepatic conditions including essential
cryoglobulinemia, glomerulonephritis, and serum autoantibody positivi
ty. New antibody tests and quantitation of HCV-RNA have allowed better
diagnosis of infectivity and monitoring of treatment effects. HCV gen
otypes are being related to the natural history of the disease and the
effects of treatment. Research continues on HCV hepatitis and other n
ewly identified viral hepatitis agents.